MALO CLINIC – Series B Financing

2017-02-26 22:45:46

MALO CLINIC closed a $12 million series B financing round with GGV Capital as the lead investor, and other investors include HighLight Capital, Shanghai Li Ying Investment Management Center etc. Haoyue Capital was the exclusive financial consultant.   

Since its establishment in 1995, MALO CLINIC sustained its exponential growth in several distinguished factors that were crucial for in just a few years becoming an international brand with global recognition in Implantology and Dental Aesthetics.

Back to 2013, MALO CLINIC entered China and opened the flagship clinic at CBD, Beijing. A quote from Mr. Shao, the chairman of MALO CLINIC China, “We hope to cooperate with more excellent professional dentist and managerial talents and partners who are engaged in high-quality dental services and have the same philosophy of professional care and ingenious spirit as MALO CLINIC so as to jointly make contribution to the development of China domestic private stomatological industry,” 

GGV Capital is managing eight funds with $3.8 billion in total, and operates in China and U.S. GGV Capital has achieved remarkable 28 IPOs exit since the establishment 16 years ago. Airbnb, Alibaba and Didi Chuxing were once backed by GGV Capital.

HighLight Capital is a venture capital and a private equity investment firm that specializes in angel, early stage, middle stage, growth capital, IPO and in PIPE investments. It typically invests in the healthcare sector. Current portfolios are Brain Doctor Group(BDG), KingYee etc. – Series B Financing Haoyue Capital at The Health Industry Summit (iHIS)